DDrare: Database of Drug Development for Rare Diseases

Searched query = "Noonan syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Glucose; Growth hormone; LOVASTATIN; Lamotrigin; Lamotrigin beta; Lovastatin; MAXOMAT ®, biosynthetic growth hormone; MEK162; Norditropin 24 IU; Norditropin SimpleXx; Other: Oral Glucose tolerance test; RhIGF-1/rhIGFBP-3; RhIGFBP-3; Simvastatin; Somatropin

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02383316 (ClinicalTrials.gov)	January 2015	23/12/2014	Study of Metabolic Modifications in Children With Noonan Syndrome	Study of Metabolic Modifications in Children With Noonan Syndrome	Child Syndrome	Other: Oral Glucose tolerance test	University Hospital, Toulouse	NULL	Completed	7 Years	18 Years	All	20	N/A	France

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02383316
(ClinicalTrials.gov)

January 2015

23/12/2014

Study of Metabolic Modifications in Children With Noonan Syndrome

Child Syndrome

Other: Oral Glucose tolerance test

University Hospital, Toulouse

NULL

Completed

7 Years

18 Years

All

N/A

France